Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zai Lab Ltd ADR (NQ: ZLAB ) 19.33 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Zai Lab Ltd ADR < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Crescendo Biologics Announces That Zai Lab Has Achieved Proof-of-Concept for ZL-1102 (Humabody®, CB001) in a Phase 1b Clinical Trial in Psoriasis Patients October 21, 2021 From Crescendo Biologics Ltd Via Business Wire Week In Review: Hansoh Signs $456 Million Deal For siRNA Products October 16, 2021 Hansoh Pharma of Shanghai announced a $456 million agreement to develop siRNA products in Greater China from South Korea's OliX Pharma. Hansoh will make an upfront payment of $6.5 million and up to... Via Talk Markets Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021 October 12, 2021 Upgrades For Callaway Golf Co (NYSE:ELY), Compass ... Via Benzinga Week In Review: MicroTech Medical Staging $245 Million HK IPO For Diabetes Products October 10, 2021 MicroTech Medical, a Hangzhou company that offers diabetes monitoring and treatment devices, is conducting a Hong Kong IPO that would raise $254 million at the top of the price range. LianBio has filed... Via Talk Markets Topics Initial Public Offering Exposures Securities Market The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More October 03, 2021 Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks. Positive tidings from Merck & Co... Via Benzinga Exposures Product Safety The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight September 19, 2021 Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results October 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... Via Benzinga Earnings Scheduled For August 9, 2021 August 09, 2021 Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... Via Benzinga Week In Review: China Life Science Posts $1.3 Billion In Deals August 07, 2021 Pacific Biosciences, a San Francisco Bay area company offering long-read sequencing platforms, will acquire Omniome for up to $800 million. Zai Lab and Schrödinger formed a collaboration to develop a... Via Talk Markets Schrödinger, Zai Lab Team Up For Cancer Program Targeting DNA Damage Response August 04, 2021 Schrödinger Inc (NASDAQ: SDGR) and Zai Lab Limited (NASDAQ: ZLAB) have collaborated to discover, develop, and commercialize oncology candidate ... Via Benzinga Schrödinger and Zai Lab Announce a Global R&D Collaboration in Oncology August 04, 2021 From Zai Lab Limited Via Business Wire Week In Review: Kumquat Signs $2 Billion US-China Deal With Lilly For Novel Immune Drugs July 31, 2021 Kumquat Biosciences announced a $2 billion agreement with a Lilly subsidiary to discover small molecule drugs that stimulate tumor-specific immune responses in cancer patients. Lilly will make a $70... Via Talk Markets 62 Biggest Movers From Yesterday July 29, 2021 Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to... Via Benzinga Topics Cannabis Exposures Cannabis 12 Health Care Stocks Moving In Wednesday's Intraday Session July 28, 2021 Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 45.98% to $2.22 during Wednesday's regular session. As of 12:30 EST, this security is trading at... Via Benzinga 50 Stocks Moving In Wednesday's Mid-Day Session July 28, 2021 Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 59.9% to $2.43. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the company highlighted the... Via Benzinga Week In Review: This Week's China Life Science Deals Total Over $2.5 Billion June 19, 2021 Shanghai's Zai Lab announced a four-drug immunonocology deal with MacroGenics worth over $1.4 billion. Shanghai's HutchMed (formerly Hutchison Chi-Med) is planning to raise $600 million in a Hong... Via Talk Markets MacroGenics, Zai Lab Ink Over $1.4B Immuno-Oncology Development Deal June 16, 2021 MacroGenics Inc (NASDAQ: MGNX) and Zai Lab Limited (NASDAQ: ZLAB) have entered into an exclusive collaboration and license agreement involving up to four... Via Benzinga Week In Review: Zai Lab Enters $338 Million Agreement To In-License KRAS Inhibitor June 05, 2021 Shanghai's Zai Lab in-licensed Greater China rights to adagrasib, a KRASG12C inhibitor, from Mirati of San Diego in a $338 million agreement. Mirati will receive a $65 million upfront payment and up to... Via Talk Markets Biotech Zai Lab Stock Sees Relative Strength Rating Jump To 83 May 14, 2021 A Relative Strength Rating upgrade for ZaiLabLimited shows improving technical performance. Via Investor's Business Daily Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs April 24, 2021 Zai Lab raised a staggering $750 million in a private placement of its dual US/Hong Kong-listed stock. It currently has a portfolio of 21 products. Zai has a market cap of $14 billion and over $1... Via Talk Markets 46 Biggest Movers From Yesterday April 21, 2021 Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares jumped 27.3% to close at $9.79 on Tuesday after the company reported inducement grants. The company recently said it... Via Benzinga The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings May 09, 2021 Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... Via Benzinga Exposures COVID-19 Product Safety 31 Stocks Moving In Tuesday's Mid-Day Session April 20, 2021 Gainers MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) gained 20.8% to $5.32 after dropping more than 10% on Monday. Takung Art Co., Ltd. (NASDAQ: TKAT) shares surged 18.2% to $21.08... Via Benzinga Amgen's Bemarituzumab Scores Breakthrough Therapy Tag For Gastric, GEJ Cancers April 20, 2021 The FDA has granted Breakthrough Therapy Designation to Amgen Inc's (NASDAQ: AMGN) bemarituzumab for patients with gastric and gastroesophageal (GEJ... Via Benzinga Exposures Product Safety 34 Stocks Moving In Tuesday's Mid-Day Session April 13, 2021 Gainers Mackinac Financial Corporation (NASDAQ: MFNC) jumped 57.6% to $20.75 after the company, and Nicolet Bankshares, jointly announced the execution of a definitive merger... Via Benzinga The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex April 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,... Via Benzinga The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead April 14, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 13) Bio-Techne Corporation (... Via Benzinga Exposures Product Safety 50 Biggest Movers From Yesterday April 14, 2021 Gainers Mackinac Financial Corporation (NASDAQ: MFNC) shares surged 60.7% to close at $21.16 on Tuesday after the company, and Nicolet Bankshares, jointly announced the execution... Via Benzinga < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.